Immunotherapeutic uses of CpG oligodeoxynucleotides

This publication has 137 references indexed in Scilit:

• Preinfection Treatment of Resistant Mice with CpG Oligodeoxynucleotides Renders Them Susceptible to Friend Retrovirus-Induced Leukemia
  Journal of Virology, 2003
• Vaccination with Novel Immunostimulatory Adjuvants against Blood-Stage Malaria in Mice
  Infection and Immunity, 2003
• Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2
  Journal of Virology, 2003
• Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells
  European Journal of Immunology, 2001
• Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis
  European Journal of Immunology, 2000
• Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia
  The Journal of Experimental Medicine, 1998
• Induction of Immune-Mediated Glomerulonephritis in Normal Mice Immunized with Bacterial DNA
  Clinical Immunology and Immunopathology, 1993
• Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
  Immunology Today, 1993
• Predominant T_H2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
  New England Journal of Medicine, 1992
• Theoretical and Experimental Approaches to Generalized Autoimmunity
  Immunological Reviews, 1990